4//SEC Filing
Vellanki Avanish 4
Accession 0000899243-22-004830
CIK 0001724979other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:30 PM ET
Size
5.5 KB
Accession
0000899243-22-004830
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+182,300→ 182,300 totalExercise: $8.02Exp: 2032-02-02→ Common Stock (182,300 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 182,300 shares of the Issuer's common stock, one quarter of which will vest on February 2, 2023, with the remaining three quarters vesting in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Therapeutics Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:30 PM ET
- Size
- 5.5 KB